<DOC>
	<DOCNO>NCT02510118</DOCNO>
	<brief_summary>The aim study evaluate synergistic anti-tumor effect ChangTai Keli base chemotherapy colon cancer patient randomize , parallel-group , double-blind , multicenter clinical study .</brief_summary>
	<brief_title>Synergistic Anti-tumor Effect ChangTai Keli Colon Cancer Patients</brief_title>
	<detailed_description>Although many therapy exist develop relieve symptom colon cancer , randomize control clinical trial evaluate comprehensive Traditional Chinese medicine ( TCM ) intervention colon cancer . The aim study evaluate synergistic anti-tumor effect ChangTai Keli base chemotherapy colon cancer patient . This multi-center , randomize , double-blind , placebo-controlled study evaluate synergistic anti-tumor effect TCM colon cancer patient . Following run-in period , approximately 360 subject randomly assign conventional chemotherapy treatment group , ChangTai Keli conventional chemotherapy treatment group 26 week . After 26 week treatment period , subject two treatment arm follow-up 36 month .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>1. collaboration hospital oncology patient hospital . Confirmed pathology cytology colon cancer , Ⅱ A Ⅳ period patient colon cancer line ( late postoperative palliative chemotherapy ) . 2. age &gt; 18 year age , 75 year old patient le ; 3. fitness score ( ECOG PS ) 2 minute less , expect lifetime &gt; 6 month ; 4. volunteer clinical research , sign inform consent . 1. patient primary malignant tumor within 1 year ; 2. intentional , severe liver kidney disease patient serious obstacle function ; 3. pregnancy lactation woman , mental disorder cooperate complete healer ; 4. subject attend drug test interval &lt; 3 month . 5. meet inclusion criterion ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>ChangTai Keli</keyword>
	<keyword>Colon cancer</keyword>
</DOC>